Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Monserrato
Clinical trial register · Italy

Clinical Trials in Monserrato, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie5 AstraZeneca3 Janssen Research & Development, LLC3 Merck Sharp & Dohme LLC3 Astria Therapeutics, Inc.2
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Monserrato

35 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AstraZeneca
Observational
218
Monserrato, Cona, San Giovanni Rotondo, Rozzano, Ancona, Bari, Brescia, Florence
2025-12-31
By invitation
Astria Therapeutics, Inc.
Phase 3
145
Milan, Monserrato
2025-10-01
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Aviano, Catania, Florence, Livorno, Meldola, Milan, Monserrato, Padova
2025-08-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Monserrato, Milan, Naples, Padova, Ravenna, Verona
2025-07-16
Recruiting
AbbVie
Observational
250
Castellana Grotte, Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Naples, Turin
2025-07-14
Active, closed
AbbVie
Phase 3
573
Monserrato, Rozzano, Milan, Naples, Rome, Bologna, Padova, Palermo
2025-06-17
Recruiting
Pfizer
Phase 2
252
Monserrato, Reggio Emilia, Rozzano, Orbassano, Salerno, Torino, Siena
2025-05-20
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
Milan, Monserrato, Padova, San Donato Milanese, Torino
2025-03-20
Active, closed
Sanofi
Phase 2
556
Torette, Monserrato, Cona, Genoa, Milan, Rozzano, Rome, Bergamo
2024-11-07
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
400
Monserrato, Milan, Naples
2024-10-24
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Bologna, Brescia, Lecco, Milan, Monserrato, Padova, Pisa, Reggio Emilia
2024-10-11
Active, closed
Eli Lilly and Company
Phase 2
143
Bologna, Brescia, Fano, Florence, Gazzi - Messina, Milan, Modena, Monserrato
2024-10-10
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
San Giovanni Rotondo, Monserrato, Viagrande, Bologna, Meldola, Monza, Frattamaggiore, Aviano
2024-09-27
Recruiting
Heart Care Foundation
Observational
5,000
Montevarchi, Acquaviva delle Fonti, Altamura, Bari, Brescia, Monserrato, Catania, Campobasso
2024-09-15
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Cona, Cuneo, Florence, Lucca, Monserrato, Naples, Peschiera del Garda, Ravenna
2024-09-12
Recruiting
AbbVie
Phase 2
590
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Rome, Turin, Negrar, Catanzaro
2024-09-04
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
16
Monserrato, Meldola, San Giovanni Rotondo, Tricase, Milan, Padova, Pisa, Prato
2024-07-23
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Monserrato, Candiolo, Genova, Milan, Naples, Padova, Pisa, Roma
2024-07-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Active, closed
AbbVie
Phase 2
156
Monserrato, Rome, Negrar
2024-03-23
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Monserrato, Avellino, Rome, Tricase, Brescia, Milan, Naples, Verona
2022-10-24
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bari, Catania, Messina, Milan, Monserrato, Monza, Negrar, Palermo
2022-09-19
Active, closed
AstraZeneca
Phase 3
341
Avellino, Aviano, Catania, Meldola, Milan, Modena, Monserrato, Naples
2022-08-03
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Bari, Catania, Messina, Milan, Monopoli, Monserrato, Monza, Negrar ( Ve)
2022-07-22
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Recruiting
University of Cagliari
Not applicable
105
Monserrato
2022-01-20
Active, closed
Nuvation Bio Inc.
Phase 2
217
Bari, Catania, Milan, Monserrato, Naples, Roma
2021-09-01
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Ancona, Monserrato, Reggio Emilia, Roma, Rozzano (MI), Verona
2021-08-30
Active, closed
University of Cagliari
Observational
970
Monserrato
2021-07-23
Active, closed
University of Campania Luigi Vanvitelli
Phase 2
219
Ancona, Acquaviva delle Fonti, Bari, Castellana Grotte, Benevento, Brindisi, Monserrato, Catania
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Recruiting
PREgnancy and FERtility Registry
NCT02895165Breast Neoplasms, Pregnancy, Fertility Preservation
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Observational
1,000
Asti, Brindisi, Monserrato, Cuneo, Cona, Genoa, Lecce, Lido di Camaiore
2012-11
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/monserrato

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Monserrato.

How many clinical trials are recruiting in Monserrato?

15 of the 35 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 18 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Monserrato), 35 studies
PhaseStudiesRecruitingShare
Phase 213337.1%
Phase 312534.3%
Observational8622.9%
Not applicable112.9%
Phase 4102.9%

Most active sponsors

Lead sponsors with the most studies (Monserrato)
Lead sponsorStudiesRecruiting
AbbVie52
AstraZeneca32
Janssen Research & Development, LLC30
Merck Sharp & Dohme LLC32
Astria Therapeutics, Inc.20
Pfizer21
University of Cagliari21
Amgen10
Bristol-Myers Squibb10
Eli Lilly and Company10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.